Intestinal Obstruction
30
2
4
15
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.7%
2 terminated out of 30 trials
88.2%
+1.7% vs benchmark
7%
2 trials in Phase 3/4
33%
5 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (30)
The Influence of Feeding Source on the Gut Microbiome and Time to Full Feeds in Neonates With Congenital Gastrointestinal Pathologies
Pelvic Floor Peritoneal Closure to Prevent Postoperative Ileus in Mid-Low Rectal Cancer Surgery
Neonatal Intestinal Obstruction: Prenatal Factors and Postnatal Outcomes
Saudi Emergency Laparotomy Audit
Capillary Leak Index as a Prognostic Indicator for Post-Operative Abdominal Sepsis in Critically Ill Patients
Impact of Interactive Video Health Intervention on Quality of Life After Bowel Obstruction Surgery
Intralipid Versus SMOFlipid in HPN Patients
Bacterial Translocation Markers as Predictors of Infectious and Inflammatory Complications in Acute Bowel Obstruction
Biological Mesh Versus Synthetic Mesh in Interdisciplinary RRP With SCP
Intestinal Microbiota and Visceral Pain in Chronic Intestinal Pseudo-Obstruction Syndrome (CIPO)
Band Adhesions in Relation to Previous Abdominal Surgery
Pathophysiology of Perioperative Fluid Management in Emergency Laparotomy
Tissue Perfusion During Emergency Laparotomy
Direct Peritoneal Resuscitation for Intra-abdominal Catastrophes
Role of Computed Tomography in Evaluation of Different Causes of Intestinal Obstruction Correlated With Operative Findings
The Role of Indocyanine Green Angiography Fluorescence on Intestinal Resections in Pediatric Surgery.
Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis
Ostomy in Continuity or Conventional Ileostomy: a Retrospective Multicentric Analysis
Quality of Life in Patients With Inoperable Malignant Bowel Obstruction
Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction